These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19350783)

  • 1. [Patient participation in decision making requires knowledge and pedagogic decision support. Examples from thrombolytic therapy in patients with atrial fibrillation].
    André M
    Lakartidningen; 2009 Feb 18-24; 106(8):506-8. PubMed ID: 19350783
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decision analysis in drawing up guidelines related to the use of anticoagulant therapy for the prevention of stroke in patients with atrial fibrillation].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Sep; 1(9):1218-9. PubMed ID: 11140298
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation.
    Anderson N; Fuller R; Dudley N
    QJM; 2007 May; 100(5):263-9. PubMed ID: 17389657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Computerised Antithrombotic Risk Assessment Tool (CARAT) to optimise therapy in older persons with atrial fibrillation.
    Bajorek BV; Masood N; Krass I
    Australas J Ageing; 2012 Jun; 31(2):102-9. PubMed ID: 22676169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic therapy in stroke prevention.
    Tilney MK
    Br J Hosp Med; 1994 Sep 7-20; 52(5):239. PubMed ID: 7820324
    [No Abstract]   [Full Text] [Related]  

  • 9. Can Shared Decision Making Improve Stroke Prevention in Atrial Fibrillation?: Implications of the Updated Guidelines.
    Brand-McCarthy SR; Delaney RK; Noseworthy PA
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e006080. PubMed ID: 32126804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evidence-based medicine: approach to a more rational medicine. Arbeitsgemeinschaft Cochrane Collaboration Schweiz].
    Bucher HC; Egger M; Schmidt JG; Antes G; Lengeler C
    Praxis (Bern 1994); 1997 Apr; 86(15):606-12. PubMed ID: 9213911
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical characteristics and antithrombotic therapy for stroke prevention in patients with atrial fibrillation].
    Tsuzuki N
    Hokkaido Igaku Zasshi; 2002 Nov; 77(6):563-70. PubMed ID: 12491628
    [No Abstract]   [Full Text] [Related]  

  • 12. Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes.
    Nieuwlaat R; Connolly SJ
    Heart; 2009 Feb; 95(2):95-7. PubMed ID: 18952632
    [No Abstract]   [Full Text] [Related]  

  • 13. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing stroke rates in patients with atrial fibrillation: how low can we go?
    Ezekowitz MD; Koti MJ; Fulton B
    Circulation; 2009 Sep; 120(13):1169-70. PubMed ID: 19752317
    [No Abstract]   [Full Text] [Related]  

  • 15. Audit, antithrombotics and atrial fibrillation--going full circle.
    Dunn RB
    Age Ageing; 2002 Sep; 31(5):327-8. PubMed ID: 12242191
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm.
    Pullicino P; Thompson JL; Mohr JP; Sacco RL; Freudenberger R; Levin B; Homma S
    Cerebrovasc Dis; 2008; 26(3):322-7. PubMed ID: 18667814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing shared decision making in diverse health care systems: the role of patient decision aids.
    O'Connor AM; Graham ID; Visser A
    Patient Educ Couns; 2005 Jun; 57(3):247-9. PubMed ID: 15893205
    [No Abstract]   [Full Text] [Related]  

  • 19. Availability of patient decision aids for stroke prevention in atrial fibrillation: A systematic review.
    O'Neill ES; Grande SW; Sherman A; Elwyn G; Coylewright M
    Am Heart J; 2017 Sep; 191():1-11. PubMed ID: 28888264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic treatment in patients with acute coronary syndromes and atrial fibrillation. What is established and what is missing.
    Tsioufis C
    Hellenic J Cardiol; 2018; 59(1):66-67. PubMed ID: 29704565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.